| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CCAAT-Enhancer-Binding Protein-alpha | 54 | 2019 | 130 | 7.060 |
Why?
|
| Trans-Activators | 50 | 2021 | 2850 | 4.370 |
Why?
|
| Hematopoietic Stem Cells | 71 | 2021 | 3401 | 4.000 |
Why?
|
| Granulocytes | 46 | 2020 | 549 | 3.870 |
Why?
|
| Proto-Oncogene Proteins | 63 | 2021 | 4520 | 3.270 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 31 | 2021 | 287 | 3.230 |
Why?
|
| Leukemia, Myeloid, Acute | 48 | 2021 | 3646 | 3.080 |
Why?
|
| Hematopoiesis | 50 | 2021 | 2058 | 2.560 |
Why?
|
| Promoter Regions, Genetic | 75 | 2021 | 5786 | 2.500 |
Why?
|
| Gene Expression Regulation, Leukemic | 28 | 2021 | 657 | 2.290 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 30 | 2021 | 350 | 2.290 |
Why?
|
| Transcription Factors | 68 | 2021 | 12131 | 2.200 |
Why?
|
| Leukemia, Myeloid | 23 | 2020 | 696 | 2.170 |
Why?
|
| Cell Differentiation | 98 | 2021 | 11641 | 2.160 |
Why?
|
| Gene Expression Regulation | 56 | 2021 | 11888 | 1.520 |
Why?
|
| Antigens, CD34 | 23 | 2012 | 656 | 1.500 |
Why?
|
| Myeloid Cells | 19 | 2021 | 839 | 1.430 |
Why?
|
| Oncogene Proteins, Fusion | 22 | 2021 | 1608 | 1.410 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 12 | 2021 | 689 | 1.300 |
Why?
|
| DNA-Binding Proteins | 41 | 2021 | 9601 | 1.140 |
Why?
|
| Neoplasm Proteins | 21 | 2018 | 3596 | 1.080 |
Why?
|
| Leukemia, Promyelocytic, Acute | 14 | 2021 | 249 | 1.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 8 | 2019 | 102 | 1.030 |
Why?
|
| Transcriptional Activation | 27 | 2021 | 1744 | 1.020 |
Why?
|
| Base Sequence | 70 | 2021 | 12403 | 0.980 |
Why?
|
| Mice | 155 | 2021 | 81819 | 0.970 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 10 | 2013 | 792 | 0.950 |
Why?
|
| Monocytes | 25 | 2019 | 2595 | 0.940 |
Why?
|
| Enhancer Elements, Genetic | 13 | 2021 | 1365 | 0.910 |
Why?
|
| Myelopoiesis | 4 | 2020 | 135 | 0.880 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 20 | 2021 | 5389 | 0.880 |
Why?
|
| Animals | 195 | 2021 | 168764 | 0.830 |
Why?
|
| Gene Expression Regulation, Neoplastic | 30 | 2021 | 8611 | 0.830 |
Why?
|
| Mice, Transgenic | 46 | 2021 | 9550 | 0.820 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 14 | 2015 | 94 | 0.810 |
Why?
|
| Fusion Proteins, bcr-abl | 7 | 2015 | 430 | 0.780 |
Why?
|
| DNA Methylation | 12 | 2019 | 4424 | 0.770 |
Why?
|
| Lung Neoplasms | 30 | 2021 | 13451 | 0.770 |
Why?
|
| Adult Stem Cells | 3 | 2015 | 221 | 0.740 |
Why?
|
| Mice, Knockout | 40 | 2021 | 14448 | 0.740 |
Why?
|
| Cell Line, Tumor | 49 | 2021 | 17075 | 0.730 |
Why?
|
| Mutation | 56 | 2021 | 30198 | 0.700 |
Why?
|
| Antineoplastic Agents | 24 | 2021 | 13648 | 0.700 |
Why?
|
| Tumor Cells, Cultured | 36 | 2021 | 6113 | 0.690 |
Why?
|
| Up-Regulation | 23 | 2020 | 4137 | 0.680 |
Why?
|
| RNA Editing | 6 | 2018 | 148 | 0.680 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 4 | 2014 | 497 | 0.680 |
Why?
|
| Neoplastic Stem Cells | 11 | 2021 | 1352 | 0.670 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2019 | 17 | 0.660 |
Why?
|
| Transcription, Genetic | 38 | 2021 | 7599 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-jun | 9 | 2007 | 287 | 0.640 |
Why?
|
| U937 Cells | 16 | 2015 | 259 | 0.620 |
Why?
|
| Carcinoma, Hepatocellular | 8 | 2021 | 2329 | 0.610 |
Why?
|
| Leukopoiesis | 8 | 2017 | 54 | 0.600 |
Why?
|
| Protein Binding | 36 | 2021 | 9296 | 0.600 |
Why?
|
| Molecular Sequence Data | 63 | 2015 | 17594 | 0.590 |
Why?
|
| Cell Line | 53 | 2021 | 15543 | 0.590 |
Why?
|
| Genes, abl | 3 | 2015 | 69 | 0.580 |
Why?
|
| Receptors, Colony-Stimulating Factor | 5 | 2020 | 51 | 0.580 |
Why?
|
| Caveolin 1 | 1 | 2019 | 255 | 0.580 |
Why?
|
| Tretinoin | 12 | 2015 | 524 | 0.560 |
Why?
|
| Cell Cycle | 12 | 2020 | 2920 | 0.560 |
Why?
|
| Lipoylation | 1 | 2018 | 87 | 0.560 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 6 | 2018 | 308 | 0.560 |
Why?
|
| Nuclear Proteins | 13 | 2015 | 5783 | 0.550 |
Why?
|
| K562 Cells | 14 | 2015 | 649 | 0.550 |
Why?
|
| Binding Sites | 36 | 2019 | 6001 | 0.530 |
Why?
|
| Translocation, Genetic | 17 | 2014 | 1394 | 0.530 |
Why?
|
| RNA, Messenger | 47 | 2017 | 12768 | 0.520 |
Why?
|
| Down-Regulation | 21 | 2017 | 2927 | 0.520 |
Why?
|
| Core Binding Factor beta Subunit | 4 | 2021 | 42 | 0.510 |
Why?
|
| Drug Resistance, Neoplasm | 12 | 2021 | 5337 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 15 | 2021 | 2844 | 0.510 |
Why?
|
| Antigens, CD | 13 | 1994 | 4025 | 0.510 |
Why?
|
| Cell Proliferation | 20 | 2021 | 10429 | 0.500 |
Why?
|
| Transfection | 24 | 2013 | 5743 | 0.500 |
Why?
|
| Liver Neoplasms | 9 | 2021 | 4353 | 0.500 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 4 | 2002 | 21 | 0.480 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 147 | 0.480 |
Why?
|
| HL-60 Cells | 12 | 2019 | 364 | 0.470 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2014 | 25 | 0.470 |
Why?
|
| CpG Islands | 1 | 2019 | 1207 | 0.470 |
Why?
|
| DNA | 27 | 2021 | 7202 | 0.460 |
Why?
|
| Signal Transduction | 23 | 2021 | 23601 | 0.460 |
Why?
|
| Neutrophils | 13 | 2019 | 3776 | 0.450 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 7 | 2017 | 633 | 0.450 |
Why?
|
| Quinazolines | 14 | 2010 | 1364 | 0.440 |
Why?
|
| SOXC Transcription Factors | 1 | 2013 | 42 | 0.440 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1140 | 0.430 |
Why?
|
| Humans | 260 | 2021 | 765968 | 0.430 |
Why?
|
| Fetal Stem Cells | 1 | 2013 | 11 | 0.430 |
Why?
|
| Gene Expression | 17 | 2021 | 7584 | 0.420 |
Why?
|
| Histones | 9 | 2021 | 2584 | 0.420 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2017 | 3607 | 0.410 |
Why?
|
| RNA-Binding Proteins | 10 | 2018 | 1874 | 0.410 |
Why?
|
| Cells, Cultured | 35 | 2021 | 18973 | 0.410 |
Why?
|
| Fanconi Anemia | 1 | 2015 | 327 | 0.410 |
Why?
|
| Luciferases | 7 | 2013 | 713 | 0.400 |
Why?
|
| Gene Expression Profiling | 26 | 2021 | 9525 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 12 | 2021 | 5696 | 0.400 |
Why?
|
| Cell Lineage | 17 | 2021 | 2573 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 33 | 2021 | 22332 | 0.400 |
Why?
|
| Bone Marrow Cells | 14 | 2017 | 2412 | 0.390 |
Why?
|
| RNA, Untranslated | 2 | 2013 | 453 | 0.390 |
Why?
|
| Liver | 12 | 2019 | 7562 | 0.390 |
Why?
|
| Leukemia | 6 | 2019 | 1522 | 0.390 |
Why?
|
| Myeloid Progenitor Cells | 8 | 2019 | 112 | 0.390 |
Why?
|
| Adenosine Deaminase | 5 | 2018 | 251 | 0.380 |
Why?
|
| Sp1 Transcription Factor | 5 | 2017 | 143 | 0.380 |
Why?
|
| Response Elements | 3 | 2018 | 307 | 0.380 |
Why?
|
| Stem Cells | 7 | 2016 | 3540 | 0.380 |
Why?
|
| Peptides | 4 | 2018 | 4331 | 0.380 |
Why?
|
| Chromatin | 9 | 2021 | 2980 | 0.370 |
Why?
|
| CDC2 Protein Kinase | 1 | 2012 | 212 | 0.370 |
Why?
|
| Mice, SCID | 12 | 2021 | 2630 | 0.370 |
Why?
|
| Erythroid Precursor Cells | 3 | 2019 | 211 | 0.370 |
Why?
|
| Apoptosis | 23 | 2021 | 9514 | 0.360 |
Why?
|
| Thermogenesis | 3 | 2021 | 496 | 0.350 |
Why?
|
| Chromatin Immunoprecipitation | 11 | 2017 | 857 | 0.350 |
Why?
|
| Serine | 6 | 2012 | 824 | 0.350 |
Why?
|
| Mice, Inbred NOD | 11 | 2021 | 1837 | 0.350 |
Why?
|
| B-Lymphocytes | 14 | 2021 | 4778 | 0.340 |
Why?
|
| Simian virus 40 | 10 | 1985 | 290 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 21 | 9 | 2014 | 228 | 0.330 |
Why?
|
| Flow Cytometry | 16 | 2020 | 5881 | 0.330 |
Why?
|
| Teratoma | 1 | 2012 | 401 | 0.330 |
Why?
|
| GATA2 Transcription Factor | 5 | 2021 | 158 | 0.310 |
Why?
|
| Neoplasm Transplantation | 8 | 2013 | 2014 | 0.310 |
Why?
|
| Histone Deacetylase Inhibitors | 5 | 2019 | 777 | 0.310 |
Why?
|
| HEK293 Cells | 13 | 2021 | 4260 | 0.310 |
Why?
|
| Dendritic Cells | 4 | 2019 | 2747 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 17 | 2015 | 4562 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2013 | 3797 | 0.310 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2019 | 227 | 0.300 |
Why?
|
| RNA, Antisense | 1 | 2008 | 135 | 0.290 |
Why?
|
| DNA Primers | 16 | 2009 | 2825 | 0.290 |
Why?
|
| Adipocytes | 5 | 2020 | 1194 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2020 | 995 | 0.290 |
Why?
|
| Cloning, Molecular | 17 | 2003 | 4165 | 0.290 |
Why?
|
| COS Cells | 6 | 2020 | 1136 | 0.290 |
Why?
|
| Azacitidine | 5 | 2015 | 334 | 0.290 |
Why?
|
| PPAR gamma | 2 | 2020 | 483 | 0.280 |
Why?
|
| Lymphocytes | 4 | 2012 | 2599 | 0.280 |
Why?
|
| Oleanolic Acid | 1 | 2007 | 43 | 0.280 |
Why?
|
| Antigens, Differentiation | 4 | 1993 | 919 | 0.280 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2015 | 1883 | 0.280 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1050 | 0.280 |
Why?
|
| Gene Knockdown Techniques | 7 | 2021 | 1599 | 0.280 |
Why?
|
| Quinazolinones | 2 | 2019 | 219 | 0.280 |
Why?
|
| Blotting, Western | 17 | 2017 | 5020 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 8 | 8 | 2014 | 451 | 0.270 |
Why?
|
| Epigenesis, Genetic | 7 | 2018 | 3819 | 0.270 |
Why?
|
| Amino Acid Sequence | 27 | 2021 | 13400 | 0.270 |
Why?
|
| Lysophospholipase | 5 | 1993 | 65 | 0.270 |
Why?
|
| Macrophage-1 Antigen | 6 | 2008 | 283 | 0.270 |
Why?
|
| Histone Demethylases | 2 | 2021 | 328 | 0.260 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 385 | 0.260 |
Why?
|
| Genes, Reporter | 12 | 2015 | 1524 | 0.260 |
Why?
|
| Leukemia, Biphenotypic, Acute | 2 | 2018 | 32 | 0.260 |
Why?
|
| MicroRNAs | 8 | 2017 | 3785 | 0.260 |
Why?
|
| Eosinophils | 10 | 1996 | 945 | 0.260 |
Why?
|
| 5' Flanking Region | 2 | 2002 | 31 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2021 | 3608 | 0.260 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2006 | 175 | 0.250 |
Why?
|
| Blood Proteins | 6 | 1993 | 1188 | 0.240 |
Why?
|
| Zinc Fingers | 6 | 2021 | 576 | 0.240 |
Why?
|
| Phosphorylation | 16 | 2020 | 8278 | 0.240 |
Why?
|
| RNA, Small Interfering | 10 | 2017 | 3421 | 0.230 |
Why?
|
| TCF Transcription Factors | 2 | 2020 | 137 | 0.230 |
Why?
|
| Macrophages | 11 | 2019 | 5772 | 0.230 |
Why?
|
| Neoplasms | 8 | 2021 | 22340 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2021 | 340 | 0.230 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 3 | 2012 | 64 | 0.230 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2015 | 891 | 0.230 |
Why?
|
| Point Mutation | 4 | 2006 | 1590 | 0.230 |
Why?
|
| Histone Acetyltransferases | 2 | 2017 | 332 | 0.230 |
Why?
|
| Pulmonary Alveoli | 2 | 2010 | 664 | 0.220 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 8 | 2021 | 5753 | 0.220 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 3 | 1994 | 281 | 0.220 |
Why?
|
| RNA, Double-Stranded | 2 | 2017 | 292 | 0.220 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2018 | 127 | 0.220 |
Why?
|
| Gene Silencing | 6 | 2018 | 1505 | 0.220 |
Why?
|
| Colony-Forming Units Assay | 7 | 2008 | 351 | 0.220 |
Why?
|
| Recombinant Fusion Proteins | 16 | 2015 | 3737 | 0.220 |
Why?
|
| Cell Nucleus | 8 | 2020 | 2867 | 0.220 |
Why?
|
| beta Catenin | 3 | 2020 | 1043 | 0.210 |
Why?
|
| RNA | 5 | 2021 | 2717 | 0.210 |
Why?
|
| CCAAT-Binding Factor | 3 | 2012 | 21 | 0.210 |
Why?
|
| HeLa Cells | 14 | 2021 | 3067 | 0.210 |
Why?
|
| Oligodeoxyribonucleotides | 7 | 1994 | 705 | 0.210 |
Why?
|
| Inosine | 3 | 2018 | 129 | 0.210 |
Why?
|
| Acute Disease | 15 | 2018 | 7232 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 14 | 2012 | 6069 | 0.200 |
Why?
|
| Methylation | 4 | 2019 | 1073 | 0.200 |
Why?
|
| Chromosome Inversion | 2 | 2021 | 120 | 0.200 |
Why?
|
| Genes, Regulator | 1 | 2003 | 373 | 0.200 |
Why?
|
| Adenocarcinoma | 9 | 2016 | 6364 | 0.200 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2021 | 394 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2003 | 1240 | 0.200 |
Why?
|
| Conserved Sequence | 2 | 2017 | 1160 | 0.190 |
Why?
|
| RNA Interference | 9 | 2018 | 2832 | 0.190 |
Why?
|
| Oncogene Proteins | 2 | 2012 | 710 | 0.190 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2011 | 490 | 0.190 |
Why?
|
| Embryonic Stem Cells | 3 | 2021 | 1241 | 0.190 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 2 | 2015 | 65 | 0.190 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 2822 | 0.190 |
Why?
|
| Cytokines | 3 | 2015 | 7421 | 0.190 |
Why?
|
| Telomerase | 2 | 2017 | 749 | 0.190 |
Why?
|
| Erythropoiesis | 2 | 2007 | 691 | 0.190 |
Why?
|
| Glycoproteins | 5 | 2004 | 2195 | 0.180 |
Why?
|
| Models, Biological | 11 | 2019 | 9443 | 0.180 |
Why?
|
| Neurotensin | 1 | 2021 | 59 | 0.180 |
Why?
|
| Immunoblotting | 4 | 2016 | 1644 | 0.180 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.180 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2021 | 58 | 0.180 |
Why?
|
| Cell Cycle Proteins | 2 | 2003 | 3430 | 0.180 |
Why?
|
| Retroviridae Proteins, Oncogenic | 6 | 1996 | 74 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2008 | 1560 | 0.180 |
Why?
|
| Burkitt Lymphoma | 2 | 2021 | 338 | 0.180 |
Why?
|
| Hemopexin | 1 | 2020 | 33 | 0.180 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 1770 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 5 | 2020 | 4772 | 0.170 |
Why?
|
| Adipocytes, Brown | 2 | 2018 | 160 | 0.170 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2020 | 152 | 0.170 |
Why?
|
| Bone Marrow | 9 | 2019 | 2921 | 0.170 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 126 | 0.170 |
Why?
|
| Obesity | 6 | 2020 | 13076 | 0.170 |
Why?
|
| Megakaryocytes | 2 | 2006 | 557 | 0.170 |
Why?
|
| Acetylation | 4 | 2016 | 1053 | 0.170 |
Why?
|
| Bone Marrow Transplantation | 6 | 2014 | 2729 | 0.170 |
Why?
|
| RNA, Neoplasm | 7 | 2005 | 745 | 0.170 |
Why?
|
| Regulatory Elements, Transcriptional | 3 | 2011 | 184 | 0.170 |
Why?
|
| Hydroxamic Acids | 3 | 2019 | 483 | 0.170 |
Why?
|
| Tetradecanoylphorbol Acetate | 7 | 1999 | 822 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 9 | 1999 | 1056 | 0.160 |
Why?
|
| Genomic Structural Variation | 1 | 2020 | 81 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 402 | 0.160 |
Why?
|
| Plasmids | 5 | 2008 | 2274 | 0.160 |
Why?
|
| ras Proteins | 2 | 2002 | 1053 | 0.160 |
Why?
|
| Blotting, Northern | 10 | 2005 | 1546 | 0.160 |
Why?
|
| Cnidaria | 1 | 1999 | 14 | 0.160 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 10261 | 0.160 |
Why?
|
| Ribonucleases | 4 | 1993 | 265 | 0.160 |
Why?
|
| Transduction, Genetic | 5 | 2015 | 898 | 0.160 |
Why?
|
| Lung | 6 | 2019 | 10033 | 0.160 |
Why?
|
| Restriction Mapping | 6 | 1998 | 848 | 0.160 |
Why?
|
| Epithelial Cells | 4 | 2021 | 3681 | 0.160 |
Why?
|
| Protein Stability | 1 | 2021 | 577 | 0.160 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2018 | 12 | 0.160 |
Why?
|
| Styrenes | 1 | 2018 | 23 | 0.150 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2017 | 115 | 0.150 |
Why?
|
| Mice, Mutant Strains | 8 | 2006 | 1745 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 2 | 2018 | 271 | 0.150 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 152 | 0.150 |
Why?
|
| Transplantation, Heterologous | 5 | 2015 | 2394 | 0.150 |
Why?
|
| Adenosine | 3 | 2018 | 806 | 0.150 |
Why?
|
| Membrane Glycoproteins | 5 | 2017 | 3690 | 0.150 |
Why?
|
| Heme | 1 | 2020 | 316 | 0.150 |
Why?
|
| Small Molecule Libraries | 2 | 2021 | 741 | 0.150 |
Why?
|
| Alkynes | 1 | 2019 | 326 | 0.150 |
Why?
|
| Sequence Deletion | 6 | 2006 | 1495 | 0.150 |
Why?
|
| Lysine | 3 | 2019 | 991 | 0.150 |
Why?
|
| Energy Metabolism | 5 | 2021 | 2892 | 0.150 |
Why?
|
| Membrane Proteins | 8 | 2017 | 7851 | 0.150 |
Why?
|
| STAT5 Transcription Factor | 3 | 2014 | 269 | 0.150 |
Why?
|
| Antigens, Viral | 7 | 1983 | 995 | 0.140 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 5 | 2010 | 440 | 0.140 |
Why?
|
| Homeodomain Proteins | 4 | 2013 | 2428 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 1998 | 312 | 0.140 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2019 | 266 | 0.140 |
Why?
|
| Receptor, Notch1 | 2 | 2013 | 517 | 0.140 |
Why?
|
| Mast Cells | 5 | 2021 | 1412 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2017 | 1167 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2015 | 691 | 0.140 |
Why?
|
| Mutant Proteins | 3 | 2008 | 488 | 0.140 |
Why?
|
| Adipocytes, White | 1 | 2018 | 92 | 0.140 |
Why?
|
| Thiazolidinediones | 1 | 2020 | 459 | 0.140 |
Why?
|
| Structure-Activity Relationship | 7 | 2019 | 3051 | 0.140 |
Why?
|
| Cluster Analysis | 6 | 2014 | 2721 | 0.140 |
Why?
|
| Myostatin | 1 | 2018 | 129 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 7 | 2021 | 2034 | 0.140 |
Why?
|
| Median Eminence | 1 | 2017 | 28 | 0.140 |
Why?
|
| Protein Structure, Quaternary | 1 | 2018 | 423 | 0.140 |
Why?
|
| Repressor Proteins | 5 | 2019 | 2968 | 0.140 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1240 | 0.140 |
Why?
|
| Receptors, Interleukin-6 | 1 | 1998 | 226 | 0.140 |
Why?
|
| Myeloproliferative Disorders | 1 | 2003 | 616 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 499 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 870 | 0.140 |
Why?
|
| DNA, Neoplasm | 7 | 2005 | 1742 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 2013 | 4913 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 157 | 0.140 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 355 | 0.140 |
Why?
|
| Creatine | 1 | 2019 | 424 | 0.140 |
Why?
|
| Gene Regulatory Networks | 4 | 2021 | 1748 | 0.130 |
Why?
|
| Multigene Family | 5 | 2015 | 1080 | 0.130 |
Why?
|
| GATA1 Transcription Factor | 4 | 2013 | 306 | 0.130 |
Why?
|
| Sialoglycoproteins | 3 | 2016 | 313 | 0.130 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 1028 | 0.130 |
Why?
|
| DNA, Viral | 9 | 1985 | 2199 | 0.130 |
Why?
|
| Chromosome Mapping | 8 | 2014 | 4618 | 0.130 |
Why?
|
| Leukocyte Elastase | 1 | 2017 | 113 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 1996 | 350 | 0.130 |
Why?
|
| Blotting, Southern | 8 | 2011 | 772 | 0.130 |
Why?
|
| Cadherins | 1 | 2021 | 900 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 2 | 2019 | 938 | 0.130 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Chromatography, Liquid | 2 | 2019 | 990 | 0.130 |
Why?
|
| Proto-Oncogenes | 2 | 1996 | 320 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Male | 43 | 2021 | 363698 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 346 | 0.130 |
Why?
|
| Coculture Techniques | 2 | 2021 | 1336 | 0.130 |
Why?
|
| Antigens, Viral, Tumor | 3 | 1985 | 151 | 0.130 |
Why?
|
| Multiprotein Complexes | 3 | 2019 | 1107 | 0.130 |
Why?
|
| DNA Ligases | 1 | 2015 | 81 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2021 | 864 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 2 | 2019 | 776 | 0.130 |
Why?
|
| Cell Division | 10 | 2009 | 4475 | 0.120 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 295 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1957 | 0.120 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 384 | 0.120 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 2 | 2021 | 38 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 870 | 0.120 |
Why?
|
| Cyclins | 3 | 2006 | 598 | 0.120 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 145 | 0.120 |
Why?
|
| Pyrazines | 1 | 2021 | 1204 | 0.120 |
Why?
|
| Leukemia, Experimental | 1 | 2015 | 225 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 1078 | 0.120 |
Why?
|
| Wnt Proteins | 3 | 2015 | 722 | 0.120 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2015 | 98 | 0.120 |
Why?
|
| Genes, Dominant | 4 | 2007 | 856 | 0.120 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 132 | 0.120 |
Why?
|
| Interleukin-3 | 3 | 2006 | 423 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 446 | 0.120 |
Why?
|
| Sequence Alignment | 6 | 2005 | 2171 | 0.120 |
Why?
|
| Protein Transport | 1 | 2020 | 1939 | 0.120 |
Why?
|
| Nucleic Acid Hybridization | 7 | 1998 | 1306 | 0.120 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 366 | 0.120 |
Why?
|
| Gene Deletion | 6 | 2017 | 2666 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2017 | 1061 | 0.110 |
Why?
|
| Integrins | 4 | 1995 | 840 | 0.110 |
Why?
|
| Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
| Erythroid Cells | 3 | 2013 | 237 | 0.110 |
Why?
|
| Lysosomes | 1 | 2020 | 932 | 0.110 |
Why?
|
| Microtubules | 1 | 2020 | 1062 | 0.110 |
Why?
|
| DNA Transposable Elements | 2 | 2015 | 765 | 0.110 |
Why?
|
| Metabolome | 1 | 2021 | 1005 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2011 | 285 | 0.110 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 195 | 0.110 |
Why?
|
| Introns | 5 | 2007 | 966 | 0.110 |
Why?
|
| Genetic Techniques | 1 | 2017 | 429 | 0.110 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 2194 | 0.110 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1995 | 173 | 0.110 |
Why?
|
| Gene Library | 5 | 2002 | 1067 | 0.110 |
Why?
|
| Fetus | 4 | 2004 | 1870 | 0.110 |
Why?
|
| Oligonucleotide Probes | 2 | 1993 | 417 | 0.110 |
Why?
|
| Multipotent Stem Cells | 2 | 2013 | 199 | 0.110 |
Why?
|
| Protein Isoforms | 8 | 2014 | 1718 | 0.110 |
Why?
|
| Receptor, Notch2 | 1 | 2014 | 90 | 0.110 |
Why?
|
| Genes, jun | 2 | 2003 | 69 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 1151 | 0.110 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 18293 | 0.110 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1992 | 53 | 0.110 |
Why?
|
| 3T3-L1 Cells | 4 | 2020 | 206 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 252 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3715 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2018 | 996 | 0.110 |
Why?
|
| Proteomics | 5 | 2019 | 3910 | 0.110 |
Why?
|
| Luciferases, Renilla | 1 | 2012 | 22 | 0.100 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 235 | 0.100 |
Why?
|
| Eczema | 1 | 2015 | 246 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1761 | 0.100 |
Why?
|
| Calcitriol | 1 | 1994 | 299 | 0.100 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2016 | 240 | 0.100 |
Why?
|
| Transgenes | 4 | 2009 | 1015 | 0.100 |
Why?
|
| Genetic Vectors | 4 | 2013 | 3404 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 2008 | 2086 | 0.100 |
Why?
|
| E2F1 Transcription Factor | 2 | 2010 | 183 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2218 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2021 | 3160 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 2453 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1229 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2014 | 1107 | 0.100 |
Why?
|
| Genes | 5 | 2010 | 1825 | 0.100 |
Why?
|
| Lymphoid Tissue | 2 | 2013 | 444 | 0.100 |
Why?
|
| Oncogenes | 2 | 2019 | 1235 | 0.100 |
Why?
|
| DNA Mutational Analysis | 6 | 2012 | 4108 | 0.100 |
Why?
|
| Octamer Transcription Factor-1 | 2 | 2005 | 30 | 0.100 |
Why?
|
| Graft Survival | 2 | 2021 | 3890 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2210 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 6 | 2007 | 3750 | 0.100 |
Why?
|
| DNA Modification Methylases | 1 | 2012 | 207 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1652 | 0.100 |
Why?
|
| E2F Transcription Factors | 2 | 2003 | 269 | 0.100 |
Why?
|
| Microcephaly | 1 | 2015 | 426 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2011 | 1657 | 0.090 |
Why?
|
| Immunomagnetic Separation | 2 | 2008 | 78 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 1996 | 1679 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2021 | 2395 | 0.090 |
Why?
|
| Receptors, Interleukin | 3 | 1999 | 243 | 0.090 |
Why?
|
| Cell Survival | 5 | 2019 | 5747 | 0.090 |
Why?
|
| Phenotype | 8 | 2021 | 16721 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 1992 | 640 | 0.090 |
Why?
|
| DNA Replication | 5 | 1985 | 1433 | 0.090 |
Why?
|
| Heterozygote | 3 | 2003 | 2794 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2013 | 1752 | 0.090 |
Why?
|
| Milk Proteins | 2 | 2005 | 161 | 0.090 |
Why?
|
| Female | 34 | 2021 | 396112 | 0.090 |
Why?
|
| Epigenomics | 1 | 2017 | 959 | 0.090 |
Why?
|
| Candidiasis | 2 | 2020 | 371 | 0.090 |
Why?
|
| E2F3 Transcription Factor | 1 | 2010 | 36 | 0.090 |
Why?
|
| NF-kappa B | 3 | 2016 | 2485 | 0.090 |
Why?
|
| Benzamides | 1 | 2016 | 1377 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2018 | 6499 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2015 | 633 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2010 | 48 | 0.090 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2011 | 62 | 0.090 |
Why?
|
| Lectins | 1 | 1993 | 487 | 0.090 |
Why?
|
| Inflammation | 5 | 2021 | 10850 | 0.090 |
Why?
|
| DNA Damage | 1 | 2020 | 2457 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2013 | 1119 | 0.090 |
Why?
|
| Integrases | 1 | 2013 | 520 | 0.090 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2010 | 40 | 0.090 |
Why?
|
| Estradiol | 3 | 2017 | 1947 | 0.090 |
Why?
|
| Glucose | 3 | 2019 | 4335 | 0.090 |
Why?
|
| Radiation Chimera | 2 | 2009 | 216 | 0.080 |
Why?
|
| Fatty Acids | 1 | 2018 | 1806 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 2 | 2007 | 47 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2014 | 903 | 0.080 |
Why?
|
| Stromal Cells | 2 | 2012 | 1329 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 1989 | 2446 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3584 | 0.080 |
Why?
|
| Myosins | 1 | 1991 | 408 | 0.080 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 3 | 2000 | 195 | 0.080 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2010 | 98 | 0.080 |
Why?
|
| Adipose Tissue | 3 | 2020 | 3312 | 0.080 |
Why?
|
| Insulin Resistance | 3 | 2020 | 3985 | 0.080 |
Why?
|
| Iodide Peroxidase | 1 | 2011 | 297 | 0.080 |
Why?
|
| Nitrophenols | 1 | 2010 | 169 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2006 | 83 | 0.080 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2009 | 49 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 2796 | 0.080 |
Why?
|
| Preleukemia | 1 | 2009 | 34 | 0.080 |
Why?
|
| Calgranulin A | 1 | 2009 | 80 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 1993 | 791 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3222 | 0.080 |
Why?
|
| Peptide Mapping | 3 | 2006 | 259 | 0.080 |
Why?
|
| Anthelmintics | 1 | 1989 | 83 | 0.080 |
Why?
|
| Cytotoxins | 1 | 1989 | 154 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 798 | 0.080 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2008 | 31 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2009 | 723 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2021 | 4752 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 195 | 0.080 |
Why?
|
| Biomimetic Materials | 1 | 2010 | 170 | 0.080 |
Why?
|
| Keratinocytes | 1 | 2012 | 863 | 0.070 |
Why?
|
| Genes, myb | 2 | 2015 | 18 | 0.070 |
Why?
|
| Biological Transport | 3 | 2019 | 2081 | 0.070 |
Why?
|
| Fetal Blood | 3 | 2011 | 1369 | 0.070 |
Why?
|
| Genes, myc | 2 | 2021 | 393 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2589 | 0.070 |
Why?
|
| Prognosis | 9 | 2017 | 29922 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3564 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 16047 | 0.070 |
Why?
|
| Proteins | 2 | 2021 | 5995 | 0.070 |
Why?
|
| Genome, Human | 2 | 2013 | 4448 | 0.070 |
Why?
|
| Leukocytes | 2 | 1995 | 2027 | 0.070 |
Why?
|
| Receptors, Estrogen | 3 | 2007 | 2242 | 0.070 |
Why?
|
| SUMO-1 Protein | 1 | 2007 | 34 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2007 | 506 | 0.070 |
Why?
|
| Blast Crisis | 2 | 2006 | 102 | 0.070 |
Why?
|
| Antigens, Surface | 2 | 1990 | 1617 | 0.070 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2007 | 141 | 0.070 |
Why?
|
| Endometrial Neoplasms | 2 | 2013 | 1378 | 0.070 |
Why?
|
| Electroporation | 1 | 2008 | 238 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 419 | 0.070 |
Why?
|
| Thymus Gland | 2 | 2017 | 1261 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 4 | 2007 | 901 | 0.070 |
Why?
|
| DNA, Complementary | 5 | 2007 | 1984 | 0.070 |
Why?
|
| Blood Cells | 1 | 2009 | 307 | 0.070 |
Why?
|
| Organ Specificity | 5 | 2005 | 1965 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2008 | 737 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 111 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 722 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3595 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2006 | 27 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 562 | 0.070 |
Why?
|
| Zinc Sulfate | 2 | 2006 | 18 | 0.070 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 196 | 0.070 |
Why?
|
| Stathmin | 1 | 2006 | 68 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 177 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 166 | 0.070 |
Why?
|
| Models, Genetic | 5 | 2008 | 3449 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2016 | 1471 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2741 | 0.060 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2007 | 262 | 0.060 |
Why?
|
| Tetracycline | 2 | 2003 | 216 | 0.060 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 660 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2880 | 0.060 |
Why?
|
| Disease Progression | 8 | 2020 | 13632 | 0.060 |
Why?
|
| Peroxidase | 1 | 1989 | 606 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 283 | 0.060 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2005 | 44 | 0.060 |
Why?
|
| Genotype | 4 | 2011 | 13024 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 422 | 0.060 |
Why?
|
| Genome | 1 | 2013 | 1753 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2015 | 229 | 0.060 |
Why?
|
| Respiratory System | 1 | 2008 | 559 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 2047 | 0.060 |
Why?
|
| Phylogeny | 1 | 1993 | 2832 | 0.060 |
Why?
|
| Karyotyping | 2 | 2004 | 1178 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 322 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 720 | 0.060 |
Why?
|
| Biolistics | 1 | 2004 | 15 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1402 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4247 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2010 | 1019 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 1996 | 323 | 0.060 |
Why?
|
| Pyridines | 1 | 2016 | 2888 | 0.060 |
Why?
|
| Genes, erbB-1 | 1 | 2005 | 161 | 0.060 |
Why?
|
| Virus Replication | 4 | 1993 | 2447 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 3 | 2015 | 661 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 360 | 0.060 |
Why?
|
| Macrophage Activation | 2 | 2007 | 552 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 416 | 0.060 |
Why?
|
| Exons | 5 | 2014 | 2391 | 0.060 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2006 | 330 | 0.060 |
Why?
|
| Spleen | 3 | 2005 | 2296 | 0.060 |
Why?
|
| Peroxidases | 2 | 1994 | 134 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2006 | 323 | 0.060 |
Why?
|
| Cell Movement | 3 | 2011 | 5194 | 0.060 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2003 | 4 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11868 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2004 | 171 | 0.050 |
Why?
|
| Tissue Distribution | 4 | 2011 | 2266 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2004 | 405 | 0.050 |
Why?
|
| Thymidine Kinase | 2 | 2006 | 286 | 0.050 |
Why?
|
| Ribosomal Proteins | 2 | 1996 | 366 | 0.050 |
Why?
|
| Cell Line, Transformed | 3 | 2004 | 858 | 0.050 |
Why?
|
| Eosinophil Granule Proteins | 3 | 1993 | 28 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 11022 | 0.050 |
Why?
|
| Adult | 16 | 2016 | 223044 | 0.050 |
Why?
|
| Aged | 15 | 2020 | 171117 | 0.050 |
Why?
|
| Deoxyribonuclease I | 2 | 2001 | 228 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2003 | 2745 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2006 | 3586 | 0.050 |
Why?
|
| G1 Phase | 2 | 2021 | 403 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2005 | 309 | 0.050 |
Why?
|
| Thrombocytosis | 1 | 2003 | 87 | 0.050 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 111 | 0.050 |
Why?
|
| 3' Flanking Region | 1 | 2002 | 14 | 0.050 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 276 | 0.050 |
Why?
|
| Genomic Library | 2 | 1993 | 189 | 0.050 |
Why?
|
| Genes, Synthetic | 2 | 2000 | 88 | 0.050 |
Why?
|
| Splenomegaly | 1 | 2003 | 192 | 0.050 |
Why?
|
| Avian Sarcoma Viruses | 2 | 1992 | 77 | 0.050 |
Why?
|
| Cyclin A | 1 | 2002 | 59 | 0.050 |
Why?
|
| Immunoglobulins | 2 | 2015 | 852 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 1988 | 1166 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Cell Transformation, Viral | 2 | 1988 | 527 | 0.050 |
Why?
|
| Multiple Myeloma | 3 | 2009 | 5197 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2021 | 37 | 0.050 |
Why?
|
| Yolk Sac | 2 | 2019 | 79 | 0.050 |
Why?
|
| Middle Aged | 16 | 2020 | 223009 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2010 | 186 | 0.050 |
Why?
|
| Cholecalciferol | 1 | 2007 | 550 | 0.050 |
Why?
|
| Leucine Zippers | 4 | 2003 | 116 | 0.050 |
Why?
|
| Calpain | 1 | 2002 | 145 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2020 | 1995 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 137 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2003 | 317 | 0.050 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 135 | 0.050 |
Why?
|
| Zebrafish | 2 | 2017 | 3036 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2002 | 170 | 0.050 |
Why?
|
| Molecular Weight | 4 | 1992 | 2163 | 0.050 |
Why?
|
| Microscopy | 1 | 2006 | 901 | 0.050 |
Why?
|
| Epithelium | 1 | 2006 | 1599 | 0.050 |
Why?
|
| Computer Systems | 1 | 2002 | 466 | 0.040 |
Why?
|
| RNA Polymerase II | 3 | 2012 | 549 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2021 | 1885 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 417 | 0.040 |
Why?
|
| Rats | 9 | 2007 | 23707 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3213 | 0.040 |
Why?
|
| Osteopontin | 2 | 1994 | 304 | 0.040 |
Why?
|
| DNA Probes | 2 | 1992 | 541 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2010 | 1984 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2020 | 157 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 1088 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1992 | 238 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 8730 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 833 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 3837 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 323 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2020 | 102 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2019 | 1885 | 0.040 |
Why?
|
| Kininogens | 1 | 2019 | 15 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2535 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 2 | 2020 | 2010 | 0.040 |
Why?
|
| Alanine | 1 | 2002 | 612 | 0.040 |
Why?
|
| Piperazines | 2 | 2010 | 2549 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2021 | 605 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 399 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11083 | 0.040 |
Why?
|
| Locus Control Region | 1 | 1998 | 21 | 0.040 |
Why?
|
| DNA Footprinting | 2 | 1995 | 97 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 399 | 0.040 |
Why?
|
| Deamination | 1 | 2018 | 25 | 0.040 |
Why?
|
| Azepines | 1 | 2021 | 327 | 0.040 |
Why?
|
| Disease-Free Survival | 4 | 2013 | 6832 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2021 | 357 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1988 | 2817 | 0.040 |
Why?
|
| Basophils | 1 | 2021 | 392 | 0.040 |
Why?
|
| Thermosensing | 1 | 2018 | 56 | 0.040 |
Why?
|
| Collagenases | 1 | 1999 | 221 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 924 | 0.040 |
Why?
|
| Haplorhini | 1 | 1999 | 520 | 0.040 |
Why?
|
| Biochemistry | 1 | 1999 | 115 | 0.040 |
Why?
|
| Forecasting | 2 | 2021 | 2936 | 0.040 |
Why?
|
| G-Quadruplexes | 1 | 2020 | 144 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 616 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2020 | 369 | 0.040 |
Why?
|
| Feedback, Physiological | 2 | 2011 | 480 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2004 | 1214 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 1740 | 0.040 |
Why?
|
| Genetic Variation | 1 | 1993 | 6610 | 0.040 |
Why?
|
| Candida albicans | 1 | 2020 | 377 | 0.040 |
Why?
|
| Neurons | 1 | 2017 | 9525 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2207 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 1202 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2018 | 163 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 502 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 151 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2007 | 2464 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 9249 | 0.030 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 1996 | 7 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 4893 | 0.030 |
Why?
|
| Solubility | 1 | 1998 | 1078 | 0.030 |
Why?
|
| Crosses, Genetic | 3 | 2005 | 752 | 0.030 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 140 | 0.030 |
Why?
|
| Peptide Fragments | 3 | 2017 | 5125 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 95 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 2464 | 0.030 |
Why?
|
| Alleles | 3 | 2020 | 6897 | 0.030 |
Why?
|
| Proteome | 1 | 2006 | 1899 | 0.030 |
Why?
|
| Host Cell Factor C1 | 1 | 1996 | 35 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3672 | 0.030 |
Why?
|
| Glutathione | 1 | 2019 | 588 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 456 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 4528 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 18071 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2017 | 296 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 576 | 0.030 |
Why?
|
| Recombinant Proteins | 6 | 2008 | 6493 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2009 | 651 | 0.030 |
Why?
|
| Integrin alphaXbeta2 | 1 | 1995 | 28 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 308 | 0.030 |
Why?
|
| Quality Control | 1 | 1999 | 837 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2016 | 98 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2016 | 262 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2006 | 2858 | 0.030 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2019 | 841 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 574 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 381 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 372 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 402 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1857 | 0.030 |
Why?
|
| Microglia | 1 | 2004 | 1372 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 743 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 515 | 0.030 |
Why?
|
| Triazoles | 1 | 2021 | 897 | 0.030 |
Why?
|
| Species Specificity | 3 | 2005 | 2406 | 0.030 |
Why?
|
| Reference Standards | 1 | 1999 | 1013 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2015 | 124 | 0.030 |
Why?
|
| Treatment Outcome | 7 | 2020 | 65188 | 0.030 |
Why?
|
| Dimerization | 2 | 2007 | 880 | 0.030 |
Why?
|
| Fetal Death | 1 | 1997 | 435 | 0.030 |
Why?
|
| Core Binding Factors | 1 | 1994 | 29 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 2548 | 0.030 |
Why?
|
| Mice, Nude | 3 | 2009 | 3618 | 0.030 |
Why?
|
| Facies | 1 | 2015 | 223 | 0.030 |
Why?
|
| Somatostatin | 1 | 2017 | 459 | 0.030 |
Why?
|
| Cell Separation | 2 | 2011 | 1718 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 679 | 0.030 |
Why?
|
| Thionucleotides | 1 | 1994 | 108 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 1994 | 78 | 0.030 |
Why?
|
| Kinetics | 4 | 2005 | 6274 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1997 | 545 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 283 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2015 | 419 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 595 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2475 | 0.030 |
Why?
|
| Mutagenesis | 2 | 1998 | 1228 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1998 | 1749 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1995 | 379 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2018 | 794 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 1994 | 155 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2018 | 550 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2011 | 11206 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2014 | 197 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 862 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2015 | 289 | 0.030 |
Why?
|
| China | 1 | 2020 | 2385 | 0.030 |
Why?
|
| Neutrophil Activation | 1 | 1994 | 180 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 250 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 572 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2015 | 287 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3356 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1995 | 353 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1992 | 421 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2015 | 305 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 768 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1028 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2015 | 294 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 4034 | 0.030 |
Why?
|
| Receptors, Interleukin-5 | 3 | 1999 | 20 | 0.030 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2013 | 58 | 0.030 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1993 | 86 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2014 | 212 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1140 | 0.030 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 63 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 1993 | 97 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2013 | 71 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 164 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 586 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1994 | 386 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1999 | 0.030 |
Why?
|
| RNA Probes | 1 | 1992 | 110 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 807 | 0.020 |
Why?
|
| Remission Induction | 2 | 2003 | 2411 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 132 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10729 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 1994 | 361 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 1994 | 602 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 995 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2015 | 494 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1870 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2007 | 561 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2018 | 2230 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 536 | 0.020 |
Why?
|
| Homeostasis | 2 | 2016 | 3336 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2006 | 660 | 0.020 |
Why?
|
| Histone Deacetylases | 2 | 2006 | 708 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 184 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 431 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 14652 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2012 | 317 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2015 | 753 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 604 | 0.020 |
Why?
|
| Galectin 3 | 1 | 1993 | 238 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2140 | 0.020 |
Why?
|
| Electricity | 1 | 1991 | 174 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 449 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 789 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.020 |
Why?
|
| tau Proteins | 1 | 2021 | 2112 | 0.020 |
Why?
|
| Ionomycin | 1 | 1990 | 109 | 0.020 |
Why?
|
| Hematology | 1 | 2014 | 243 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1991 | 348 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1759 | 0.020 |
Why?
|
| Time Factors | 6 | 2011 | 40065 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2011 | 10070 | 0.020 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 1 | 1990 | 22 | 0.020 |
Why?
|
| Cyclohexanols | 1 | 2010 | 127 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1990 | 339 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1993 | 561 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 518 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 2010 | 218 | 0.020 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2009 | 36 | 0.020 |
Why?
|
| Chickens | 1 | 1991 | 842 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 1481 | 0.020 |
Why?
|
| Cathepsin G | 1 | 2009 | 41 | 0.020 |
Why?
|
| Piperidines | 2 | 2009 | 1664 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8529 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3655 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3211 | 0.020 |
Why?
|
| Leptin | 1 | 2017 | 1596 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2709 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2157 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 827 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1988 | 37 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 1990 | 389 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 359 | 0.020 |
Why?
|
| Receptors, Vitronectin | 1 | 1988 | 49 | 0.020 |
Why?
|
| Polycythemia Vera | 1 | 2010 | 160 | 0.020 |
Why?
|
| Cannabinoids | 1 | 2010 | 174 | 0.020 |
Why?
|
| Cathepsins | 1 | 2009 | 242 | 0.020 |
Why?
|
| Filgrastim | 1 | 2008 | 131 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2007 | 91 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2010 | 2216 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2004 | 2669 | 0.020 |
Why?
|
| Clone Cells | 2 | 2006 | 1672 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1999 | 812 | 0.020 |
Why?
|
| Drug Design | 1 | 2013 | 1042 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1975 | 2002 | 0.020 |
Why?
|
| Leukapheresis | 1 | 2008 | 150 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 1216 | 0.020 |
Why?
|
| Thiazoles | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Critical Illness | 1 | 2020 | 2744 | 0.020 |
Why?
|
| Plicamycin | 1 | 2007 | 12 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
| Blood Glucose | 2 | 2016 | 6424 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 839 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1991 | 751 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1993 | 1072 | 0.020 |
Why?
|
| Adolescent | 4 | 2014 | 88835 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 70 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2007 | 189 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 1992 | 2120 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2020 | 41649 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3800 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20124 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1988 | 1300 | 0.020 |
Why?
|
| Adiposity | 1 | 2016 | 1890 | 0.020 |
Why?
|
| Trichinella | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2006 | 198 | 0.020 |
Why?
|
| Poly C | 1 | 2005 | 6 | 0.020 |
Why?
|
| Poly I | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2005 | 54 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2005 | 14 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2005 | 26 | 0.020 |
Why?
|
| Insulin | 1 | 2020 | 6599 | 0.020 |
Why?
|
| Glucose-6-Phosphate | 1 | 2005 | 29 | 0.020 |
Why?
|
| Thrombin | 1 | 1988 | 602 | 0.020 |
Why?
|
| Algorithms | 1 | 2006 | 14071 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2005 | 70 | 0.020 |
Why?
|
| Aging | 1 | 2004 | 8731 | 0.020 |
Why?
|
| Interferons | 1 | 2009 | 714 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2011 | 1404 | 0.020 |
Why?
|
| DNA, Circular | 2 | 1976 | 97 | 0.020 |
Why?
|
| Retroviridae | 1 | 2008 | 847 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2005 | 116 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2005 | 64 | 0.020 |
Why?
|
| Streptozocin | 1 | 2005 | 189 | 0.020 |
Why?
|
| Glucokinase | 1 | 2005 | 98 | 0.020 |
Why?
|
| Drosophila | 1 | 1993 | 1501 | 0.020 |
Why?
|
| Hot Temperature | 3 | 1983 | 1433 | 0.020 |
Why?
|
| Chimera | 2 | 1997 | 455 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 2942 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2010 | 839 | 0.010 |
Why?
|
| Phospholipids | 1 | 1989 | 776 | 0.010 |
Why?
|
| Mitochondria | 1 | 2018 | 3673 | 0.010 |
Why?
|
| Glycogen | 1 | 2005 | 251 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 439 | 0.010 |
Why?
|
| Models, Structural | 1 | 2005 | 338 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 59489 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2007 | 639 | 0.010 |
Why?
|
| Eosinophil Peroxidase | 2 | 1994 | 22 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2060 | 0.010 |
Why?
|
| Dystroglycans | 1 | 2004 | 62 | 0.010 |
Why?
|
| PPAR alpha | 1 | 2005 | 175 | 0.010 |
Why?
|
| R-SNARE Proteins | 1 | 2004 | 73 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 36386 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2900 | 0.010 |
Why?
|
| Antibodies | 1 | 2012 | 2417 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 674 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 515 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1024 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1210 | 0.010 |
Why?
|
| Models, Molecular | 2 | 2004 | 5379 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 448 | 0.010 |
Why?
|
| Survival Rate | 2 | 2010 | 12795 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 42500 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 2005 | 327 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 4860 | 0.010 |
Why?
|
| Leukocytosis | 1 | 2004 | 248 | 0.010 |
Why?
|
| Intracellular Space | 1 | 2004 | 198 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 703 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 185 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 1992 | 1587 | 0.010 |
Why?
|
| Life Tables | 1 | 2003 | 363 | 0.010 |
Why?
|
| Wound Healing | 1 | 2013 | 2792 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2014 | 3081 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 885 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1188 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2004 | 563 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2011 | 10383 | 0.010 |
Why?
|
| Macaca | 1 | 1983 | 413 | 0.010 |
Why?
|
| Base Composition | 1 | 1982 | 291 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2002 | 118 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1988 | 1612 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2007 | 718 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 1415 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2006 | 963 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1993 | 4214 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1983 | 780 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 1467 | 0.010 |
Why?
|
| Eosinophil-Derived Neurotoxin | 2 | 1992 | 13 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2013 | 9373 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2007 | 1113 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2004 | 565 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1982 | 209 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1981 | 255 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2003 | 393 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2132 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1417 | 0.010 |
Why?
|
| Quinolines | 1 | 2006 | 769 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 507 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2015 | 3459 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Temperature | 2 | 1977 | 2226 | 0.010 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1880 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6220 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2056 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2005 | 807 | 0.010 |
Why?
|
| Ion Channels | 1 | 2004 | 1045 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 1178 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2007 | 3537 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 675 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1325 | 0.010 |
Why?
|
| Yeasts | 1 | 1999 | 278 | 0.010 |
Why?
|
| Diet | 1 | 2016 | 8086 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3513 | 0.010 |
Why?
|
| Prostate | 1 | 2006 | 1755 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 1534 | 0.010 |
Why?
|
| Child | 1 | 2006 | 80564 | 0.010 |
Why?
|
| Triglycerides | 1 | 2005 | 2441 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12807 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 3089 | 0.010 |
Why?
|
| Carcinoma | 1 | 1988 | 2312 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 1724 | 0.010 |
Why?
|
| Astrocytes | 1 | 2004 | 1345 | 0.010 |
Why?
|
| Receptors, Erythropoietin | 1 | 1996 | 145 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2898 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3602 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1602 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1977 | 477 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2423 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
| HIV-1 | 1 | 1993 | 6944 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1995 | 222 | 0.010 |
Why?
|
| Germinal Center | 1 | 1997 | 379 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 4622 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1994 | 51 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3046 | 0.010 |
Why?
|
| Computational Biology | 1 | 2006 | 3559 | 0.010 |
Why?
|
| Brain | 1 | 2021 | 27171 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1081 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1996 | 414 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1994 | 456 | 0.010 |
Why?
|
| Butyrates | 1 | 1994 | 162 | 0.010 |
Why?
|
| Cricetinae | 1 | 1977 | 2411 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8102 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 955 | 0.010 |
Why?
|
| Biopsy | 1 | 2005 | 6763 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 220 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1997 | 1528 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 315 | 0.010 |
Why?
|
| Sialomucins | 1 | 1992 | 18 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1992 | 528 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1993 | 251 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39193 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 3775 | 0.010 |
Why?
|
| Amino Acids | 1 | 1977 | 1709 | 0.010 |
Why?
|
| Risk | 1 | 2003 | 9591 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1996 | 1144 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1996 | 2601 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 4427 | 0.010 |
Why?
|
| Mucins | 1 | 1992 | 567 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2476 | 0.000 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1989 | 86 | 0.000 |
Why?
|
| Protein Sorting Signals | 1 | 1989 | 273 | 0.000 |
Why?
|
| Artifacts | 1 | 1995 | 1893 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 5501 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2003 | 26346 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 54802 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 81514 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1976 | 548 | 0.000 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1976 | 111 | 0.000 |
Why?
|
| Complement Fixation Tests | 1 | 1975 | 67 | 0.000 |
Why?
|
| Risk Factors | 1 | 2003 | 74840 | 0.000 |
Why?
|
| Coliphages | 1 | 1975 | 121 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1975 | 289 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 340 | 0.000 |
Why?
|
| Drug Stability | 1 | 1975 | 288 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1981 | 2864 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1975 | 1430 | 0.000 |
Why?
|